Volume 10, Number 3—March 2004
Dispatch
Adherence Barriers to Antimicrobial Treatment Guidelines in Teaching Hospital, the Netherlands
Table 2
Barriers identified | Proposed interventions | |
---|---|---|
Guideline |
1. Dissemination
2. Credibility of content |
1. Develop and actively distribute hard-copy and electronic version
2. Incorporate departmental policies, and update regularly
− For both 1 and 2, organize meetings to introduce guidelines and set up an active outreach committee |
Physician
Readiness to change or use the guideline |
Supervising specialists
3. No need for a guideline, because
− Routine prescribing
− No perceived resistance problems
4. Autonomy |
3. A combination of group and individual feedback (“academic detailing”) to supervisors and residents
4. Incorporate specialists/departmental views in guideline (see 2, above) |
Residents
5. Insufficient knowledge
− Of culture results
− Low self-efficacy regarding streamlining |
5. Active educational support on interpretation of culture-results and for streamlining therapy |
|
Infectious disease consultants
6. Overestimate the feasibility of an intervention |
6. Check support before implementation of an intervention |
|
Social and institutional context | 7. Residents are not independent decision makers and their prescribing decisions are supervised by specialists 8. Infectious disease consultant secondary to supervisor 9. Different guidelines between departments | 7. Target both residents and supervising specialists 8. Target supervisor, formalize advice of consultants 9. Incorporate departmental policies (see 2 and 5, above) |
1A paper “critical-pathway” combines an antimicrobial drug order form with a decision support tool. Filling out a few relevant case-characteristics guides the prescriber to the guideline’s recommendation for that specific case.
Page created: February 08, 2011
Page updated: February 08, 2011
Page reviewed: February 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.